South Korea Anticoagulants Market Size & Outlook, 2026-2033
Related Markets
South Korea anticoagulants market highlights
- The South Korea anticoagulants market generated a revenue of USD 767.5 million in 2025 and is expected to reach USD 1,286.6 million by 2033.
- The South Korea market is expected to grow at a CAGR of 6.8% from 2026 to 2033.
- In terms of segment, novel oral anticoagulants (noacs) was the largest revenue generating drug category in 2025.
- Direct Thrombin Inhibitors is the most lucrative drug category segment registering the fastest growth during the forecast period.
Anticoagulants market data book summary
| Market revenue in 2025 | USD 767.5 million |
| Market revenue in 2033 | USD 1,286.6 million |
| Growth rate | 6.8% (CAGR from 2026 to 2033) |
| Largest segment | Novel oral anticoagulants (noacs) |
| Fastest growing segment | Direct Thrombin Inhibitors |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vitamin K Antagonist, Direct Thrombin Inhibitors, Novel Oral Anticoagulants (NOACs), Heparin |
| Key market players worldwide | Aspen Group Inc, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, Sanofi SA, Bayer AG, Boehringer Ingelheim, Daiichi Sankyo Co Ltd, Johnson & Johnson, Eisai Co Ltd |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.1% of the global anticoagulants market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China anticoagulants market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,501.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulants Market Scope
Anticoagulants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eisai Co Ltd | View profile | 11076 | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 | http://www.eisai.co.jp |
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Aspen Group Inc | View profile | 1133 | 276 Fifth Avenue, Suite 505, New York, NY, United States, 10001 | https://www.aspu.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
South Korea anticoagulants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.
Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 60.33% in 2025. Horizon Databook has segmented the South Korea anticoagulants market based on vitamin k antagonist, direct thrombin inhibitors, novel oral anticoagulants (noacs), heparin covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Korea anticoagulants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea anticoagulants market databook
-
Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea anticoagulants market , including forecasts for subscribers. This country databook contains high-level insights into South Korea anticoagulants market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea anticoagulants market size, by drug category, 2021-2033 (US$M)
South Korea Anticoagulants Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
